Beta Bionics (NASDAQ:BBNX) Now Covered by Analysts at Stifel Nicolaus
Stifel Nicolaus started coverage on shares of Beta Bionics (NASDAQ:BBNX – Free Report) in a research report report published on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $25.00 price objective on the stock. A number of other brokerages also recently issued reports on BBNX. LADENBURG THALM/SH SH initiated coverage […]
